Advertisement

Managing Periocular Filler-Related Syndrome Prior to Lower Blepharoplasty

  • Christopher I. Zoumalan
Original Article Oculoplastic
  • 29 Downloads

Abstract

Background

Hyaluronic acid (HA) fillers are extensively used in periocular volume augmentation. Although they have an excellent safety profile, filler-related issues such as visibility/palpability, contour abnormalities, malar edema, and blue-gray dyschromia can occur. Recognition and management of filler-related issues are critical prior to subsequent procedures. The clinical course of patients who had periocular HA filler-related issues and subsequently underwent lower eyelid blepharoplasty is described.

Methods

HA filler was dissolved with hyaluronidase (15–30 U/cm2) treatment. Visible lower eyelid fat prolapse after filler removal was corrected with transconjunctival blepharoplasty with fat repositioning and skin resurfacing. Complications and outcome were assessed and recorded.

Results

Twenty-three patients (46 eyelids) were treated. All presented with contour abnormalities, 19 with contour abnormalities and malar edema, and seven with blue-gray dyschromia. In 15 patients, one session of hyaluronidase completely dissolved the filler, and in eight patients, two sessions were required. Of these eight patients, edema resolved after the second hyaluronidase injection in four; in the remaining four, mild edema persisted despite absence of visible/palpable filler. Postblepharoplasty, 19 patients had an acceptable outcome with no complications (82.6%). Four patients had prolonged edema postoperatively; three had a resolution by 6 months. In 23 patients who had skin resurfacing procedures, there was no incidence of postinflammatory hyperpigmentation.

Conclusions

HA filler-related issues need to be identified and managed prior to further intervention. Hyaluronidase treatment effectively dissolves the filler, but mild malar edema can persist. Outcomes are acceptable after subsequent blepharoplasty, but adequate patient counseling is necessary about expectations and limitations.

Level of Evidence IV

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.

Keywords

Hyaluronic acid Under eye fillers Infraorbital rim hollowing Tear trough deformity Hyaluronidase Blepharoplasty 

Notes

Compliance with Ethical Standards

Conflict of interest

Christopher I. Zoumalan, MD, FACS, is a consultant for Allergan, Irvine, CA, and owns stock and is the scientific advisor for MD Medical Designs, Inc., Los Angeles, CA.

References

  1. 1.
    Lee S, Yen MT (2017) Nonsurgical rejuvenation of the eyelids with hyaluronic acid gel injections. Semin Plast Surg 31:17–21CrossRefGoogle Scholar
  2. 2.
    Goldberg RA, Fiaschetti D (2006) Filling the periorbital hollows with hyaluronic acid gel: initial experience with 244 injections. Ophthalmic Plast Reconstr Surg 22:335–341CrossRefGoogle Scholar
  3. 3.
    Mustak H, Fiaschetti D, Goldberg RA (2017) Filling the periorbital hollows with hyaluronic acid gel: long-term review of outcomes and complications. J Cosmet Dermatol.  https://doi.org/10.1111/jocd.12452 CrossRefPubMedGoogle Scholar
  4. 4.
    American Society of Plastic Surgeons (2017) Plastic surgery statistics report. https://www.plasticsurgery.org/documents/News/Statistics/2017/plastic-surgery-statistics-report-2017.pdf Accessed May 2018
  5. 5.
    Weinberg MJ, Solish N (2009) Complications of hyaluronic acid fillers. Facial Plast Surg 25:324–328CrossRefGoogle Scholar
  6. 6.
    Park TH, Seo SW, Kim JK, Chang CH (2011) Clinical experience with hyaluronic acid-filler complications. J Plast Reconstr Aesthet Surg 64:892–896CrossRefGoogle Scholar
  7. 7.
    Dayan SH, Arkins JP, Somenek M (2012) Restylane persisting in lower eyelids for 5 years. J Cosmet Dermatol 11:237–238CrossRefGoogle Scholar
  8. 8.
    Jordan DR, Stoica B (2015) Filler migration: a number of mechanisms to consider. Ophthal Plast Reconstr Surg 31:257–262CrossRefGoogle Scholar
  9. 9.
    Teo AA, Mokhtarzadeh A, Cameron JD, Harrison AR (2017) Late presentation of enlarging lower eyelid mass and muscle degeneration secondary to hyaluronic acid filler. Ophthal Plast Reconstr Surg 33:S9–S11CrossRefGoogle Scholar
  10. 10.
    Khan TT, Woodward JA (2015) Retained dermal filler in the upper eyelid masquerading as periorbital edema. Dermatol Surg 41:1182–1184CrossRefGoogle Scholar
  11. 11.
    Zoumalan CI, Roostaeian J (2016) Simplifying blepharoplasty. Plast Reconstr Surg 137:196e–213eCrossRefGoogle Scholar
  12. 12.
    Taban MR (2017) Lower eyelid blepharoplasty in eyelids previously injected with hyaluronic acid gel filler. Am J Cosmetic Surg 34:103–106CrossRefGoogle Scholar
  13. 13.
    Hagan JC 3rd, Hill WE (2001) Use of a compounding pharmacy hyaluronidase for ophthalmic injection anesthesia. J Cataract Refract Surg 27:1712–1714CrossRefGoogle Scholar
  14. 14.
    Micheels P, Sarazin D, Tran C, Salomon D (2016) Effect of different crosslinking technologies on hyaluronic acid behavior: a visual and microscopic study of seven hyaluronic acid gels. J Drugs Dermatol 15:600–606PubMedGoogle Scholar
  15. 15.
    Sundaram H, Cassuto D (2013) Biophysical characteristics of hyaluronic acid soft-tissue fillers and their relevance to aesthetic applications. Plast Reconstr Surg 132:5S–21SCrossRefGoogle Scholar
  16. 16.
    Sundaram H, Rohrich RJ, Liew S et al (2015) Cohesivity of hyaluronic acid fillers: development and clinical implications of a novel assay, pilot validation with a five-point grading scale, and evaluation of six U.S. Food and Drug Administration-approved fillers. Plast Reconstr Surg 136:678–686CrossRefGoogle Scholar
  17. 17.
    Yu JTS, Peng L, Ataullah S (2017) Chronic eyelid edema following periocular hyaluronic acid filler treatment. Ophthal Plast Reconstr Surg 33:e139–e140CrossRefGoogle Scholar
  18. 18.
    Iverson SM, Patel RM (2017) Dermal filler-associated malar edema: treatment of a persistent adverse effect. Orbit 36:473–475CrossRefGoogle Scholar
  19. 19.
    Cavallini M, Gazzola R, Metalla M, Vaienti L (2013) The role of hyaluronidase in the treatment of complications from hyaluronic acid dermal fillers. Aesthet Surg J 33:1167–1174CrossRefGoogle Scholar
  20. 20.
    Hilton S, Schrumpf H, Buhren BA et al (2014) Hyaluronidase injection for the treatment of eyelid edema: a retrospective analysis of 20 patients. Eur J Med Res 19:30CrossRefGoogle Scholar
  21. 21.
    Menon H, Thomas M, D silva J (2010) Low dose of Hyaluronidase to treat over correction by HA filler–a case report. J Plast Reconstr Aesthet Surg 63:e416–e417CrossRefGoogle Scholar
  22. 22.
    Pierre A, Levy PM (2007) Hyaluronidase offers an efficacious treatment for inaesthetic hyaluronic acid overcorrection. J Cosmet Dermatol 6:159–162CrossRefGoogle Scholar
  23. 23.
    Lambros V (2004) The use of hyaluronidase to reverse the effects of hyaluronic acid filler. Plast Reconstr Surg 114:277CrossRefGoogle Scholar
  24. 24.
    DeLorenzi C (2013) Complications of injectable fillers, part I. Aesthet Surg J 33:561–575CrossRefGoogle Scholar
  25. 25.
    Juhász MLW, Levin MK, Marmur ES (2017) The kinetics of reversible hyaluronic acid filler injection treated with hyaluronidase. Dermatol Surg 43:841–847CrossRefGoogle Scholar
  26. 26.
    Casabona G, Marchese PB, Montes JR, Hornfeldt CS (2018) Durability, behavior, and tolerability of 5 hyaluronidase products. Dermatol Surg.  https://doi.org/10.1097/DSS.0000000000001562 CrossRefPubMedGoogle Scholar
  27. 27.
    Brightman LA, Brauer JA, Anolik R et al (2009) Ablative and fractional ablative lasers. Dermatol Clin 27:479–489CrossRefGoogle Scholar
  28. 28.
    Han SH, Kim HJ, Kim SY et al (2011) Skin rejuvenating effects of chemical peeling: a study in photoaged hairless mice. Int J Dermatol 50:1075–1082CrossRefGoogle Scholar
  29. 29.
    Alster TS, Graham PM (2018) Microneedling: a review and practical guide. Dermatol Surg 44:397–404PubMedGoogle Scholar
  30. 30.
    Kitano Y, Yoshimura K, Uchida G et al (2001) Pretreatment with topical all-trans-retinoic acid is beneficial for wound healing in genetically diabetic mice. Arch Dermatol Res 293:515–521CrossRefGoogle Scholar
  31. 31.
    de Campos Peseto D, Carmona EV, Silva KC et al (2016) Effects of tretinoin on wound healing in aged skin. Wound Repair Regen 24:411–417CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature and International Society of Aesthetic Plastic Surgery 2018

Authors and Affiliations

  1. 1.Keck School of MedicineUniversity of Southern CaliforniaBeverly HillsUSA

Personalised recommendations